发明名称 |
Peptide vaccines comprising Seq Id 101, 80 or 100 for cancers expressing tumor-associated antigens |
摘要 |
The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 101, 80 or 100 as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the ECT2, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines.
|
申请公布号 |
EP2573109(A2) |
申请公布日期 |
2013.03.27 |
申请号 |
EP20120175479 |
申请日期 |
2008.02.21 |
申请人 |
ONCOTHERAPY SCIENCE, INC. |
发明人 |
TSUNODA, TAKUYA;OHSAWA, RYUJI |
分类号 |
C07K14/47;A61K39/00;A61P35/00;C07K14/745;C12N5/10;G01N33/15;G01N33/50 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|